Page last updated: 2024-10-22

arotinolol and Obesity

arotinolol has been researched along with Obesity in 1 studies

arotinolol: structure given in first source; arotinolol is the (+-)-isomer

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshida, T1
Sakane, N1
Wakabayashi, Y1
Yoshioka, K1
Umekawa, T1
Kondo, M1

Other Studies

1 other study available for arotinolol and Obesity

ArticleYear
The alpha/beta-adrenergic receptor blocker arotinolol activates the thermogenesis of brown adipose tissue in monosodium-L-glutamate-induced obese mice.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1994, Volume: 18, Issue:5

    Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; An

1994